|Delivery||Report Code||Available Format|
|24-72 Working Hours||LS10475|
The increasing prevalence of neurological disorders and growing aging population around the world are the predominant growth drivers for the global gamma knife market. In addition, the technological advancement in radiosurgery systems including gamma knife, and initiatives taken by various government associations to raise awareness about therapeutic applications of radiation therapy systems in the treatment of brain tumors are also driving the growth of the global gamma knife market. In terms of therapeutic applications, brain metastases hold the largest share in the global gamma knife market. On the basis of anatomy, head is the largest and fastest growing segment in the global gamma knife market.
Gamma Knife uses tiny beams of radiation for the treatment of tumor and carcinogenic regions of the body. It is most often used in the treatment of neurological conditions, such as brain metastases, acoustic neuroma, and trigeminal neuralgia.
The stringent regulations for the approval of gamma knife system and high installation and maintenance costs are some of the factors, restraining the growth of the global gamma knife market. Moreover, the lack of skilled healthcare professionals to operate gamma knife, risks of side-effects associated with radiological elements, and lack of awareness about therapeutic applications of gamma knife are also hindering the growth of the global gamma knife market, especially in the developing countries. However, the countries, such as China and India are expected to witness considerable growth during the forecast period, due to improving healthcare infrastructure and increasing prevalence of neurological disorders.
North America and Europe are the major markets of gamma knife, due to the improved healthcare infrastructure and growing demand for radiosurgery systems. The U.S., followed by Canada, is the largest market for gamma knife in North America. Whereas, Germany, the U.K., France, and Italy are some of the major countries holding significant shares in the European gamma knife market.
The Asia-Pacific gamma knife market is growing with a significant rate, owing to improving healthcare infrastructure and increasing prevalence of neurological disorders in the region. In addition, the increasing awareness about therapeutic applications of Gamma Knife, growing aging population, and initiatives taken by various government applications to raise awareness about cancer and neurological disorders, and their treatment procedures are also supporting the growth of the Asia- Pacific gamma knife market. The countries, such as India, Japan, and China are the major markets for gamma knife in the region.
Apart from these regions, Latin America is other important market for gamma knife. This is due to increasing R&D investments in the manufacturing of radiosurgery equipment within the low manufacturing cost regions, including Latin America. Brazil holds the largest share in the Latin American gamma knife market, due to the increasing prevalence of cancer and improving healthcare infrastructure in the country.
Some of the major players operating in the global gamma knife market include American Shared Hospital Services, ET Medical Group, Nordion Inc., Masep Infini Global Inc., Cyber Medical Corporation Limited, Huiheng Medical Inc., Elekta AB, Varian Medical Systems Inc, and Hokai.
Gamma Knife Market Segmentation